Last updated: 16 July 2019 at 5:59pm EST

Jeffrey Bacha Net Worth




The estimated Net Worth of Jeffrey Bacha is at least $85.4 Thousand dollars as of 6 October 2017. Jeffrey Bacha owns over 10,000 units of DelMar Pharmaceuticals stock worth over $85,354 and over the last 11 years Jeffrey sold DMPI stock worth over $0.

Jeffrey Bacha DMPI stock SEC Form 4 insiders trading

Jeffrey has made over 18 trades of the DelMar Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Jeffrey bought 10,000 units of DMPI stock worth $8,700 on 6 October 2017.

The largest trade Jeffrey's ever made was buying 50,000 units of DelMar Pharmaceuticals stock on 16 July 2015 worth over $30,000. On average, Jeffrey trades about 4,806 units every 44 days since 2013. As of 6 October 2017 Jeffrey still owns at least 63,697 units of DelMar Pharmaceuticals stock.

You can see the complete history of Jeffrey Bacha stock trades at the bottom of the page.



What's Jeffrey Bacha's mailing address?

Jeffrey's mailing address filed with the SEC is SUITE 720-999 WEST BROADWAY, , VANCOUVER, A1, V5Z 1K5.

Insiders trading at DelMar Pharmaceuticals

Over the last 11 years, insiders at DelMar Pharmaceuticals have traded over $104,000 worth of DelMar Pharmaceuticals stock and bought 663,835 units worth $651,854 . The most active insiders traders include John K Bell, Robert Hoffman, and Jeffrey Bacha. On average, DelMar Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $20,766. The most recent stock trade was executed by John K Bell on 13 September 2019, trading 35,000 units of DMPI stock currently worth $23,800.



What does DelMar Pharmaceuticals do?

DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.



What does DelMar Pharmaceuticals's logo look like?

DelMar Pharmaceuticals, Inc. logo

Complete history of Jeffrey Bacha stock trades at DelMar Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 Oct 2017 Jeffrey Bacha
Chief Executive Officer
Buy 10,000 $0.87 $8,700
6 Oct 2017
63,697
26 Jun 2017 Jeffrey Bacha
Chief Executive Officer
Buy 6,700 $3.60 $24,120
26 Jun 2017
53,345
6 Jun 2017 Jeffrey Bacha
Chief Executive Officer
Buy 5,000 $2.12 $10,600
6 Jun 2017
46,645
5 May 2017 Jeffrey Bacha
Chief Executive Officer
Buy 2,500 $2.20 $5,500
5 May 2017
41,645
1 Feb 2017 Jeffrey Bacha
Chief Executive Officer
Buy 4,000 $5.00 $20,000
1 Feb 2017
38,969
25 Nov 2015 Jeffrey Bacha
Chief Executive Officer
Buy 7,500 $1.47 $11,025
25 Nov 2015
137,985
8 Oct 2015 Jeffrey Bacha
Chief Executive Officer
Buy 3,000 $0.80 $2,400
8 Oct 2015
130,485
18 Sep 2015 Jeffrey Bacha
Chief Executive Officer
Buy 4,000 $0.83 $3,320
18 Sep 2015
127,485
25 Jul 2015 Jeffrey Bacha
Chief Executive Officer
Buy 10,000 $0.60 $6,000
25 Jul 2015
123,485
16 Jul 2015 Jeffrey Bacha
Chief Executive Officer
Buy 50,000 $0.60 $30,000
16 Jul 2015
113,485
22 Jan 2015 Jeffrey Bacha
Chief Executive Officer
Buy 7,500 $0.66 $4,950
22 Jan 2015
63,485
9 Dec 2014 Jeffrey Bacha
Chief Executive Officer
Buy 2,500 $0.90 $2,250
9 Dec 2014
55,985
26 Nov 2014 Jeffrey Bacha
Chief Executive Officer
Buy 2,500 $0.92 $2,300
26 Nov 2014
53,485
18 Sep 2014 Jeffrey Bacha
Chief Executive Officer
Buy 4,000 $0.98 $3,920
18 Sep 2014
50,985
15 Sep 2014 Jeffrey Bacha
Chief Executive Officer
Buy 4,985 $0.75 $3,739
15 Sep 2014
46,985
18 Mar 2014 Jeffrey Bacha
Chief Executive Officer
Buy 10,000 $1.30 $13,000
18 Mar 2014
42,000
21 Feb 2014 Jeffrey Bacha
Chief Executive Officer
Buy 5,000 $1.00 $5,000
21 Feb 2014
32,000
13 Feb 2014 Jeffrey Bacha
Chief Executive Officer
Buy 5,000 $0.80 $4,000
13 Feb 2014
27,000


DelMar Pharmaceuticals executives and stock owners

DelMar Pharmaceuticals executives and other stock owners filed with the SEC include: